Equillium, Inc. is a clinical-stage biotechnology company headquartered in La Jolla, California, dedicated to developing novel therapeutics for severe autoimmune and inflammatory disorders that currently have no effective treatment options. Utilizing its proprietary platform, the company focuses on innovative therapies that target specific immuno-inflammatory pathways, thereby positioning itself as a leader in addressing complex diseases. With a promising pipeline of clinical candidates, Equillium aims to satisfy significant unmet medical needs and enhance patient outcomes in the biopharmaceutical industry.
Click "Analyze" to generate stock analysis
EQ Price Trend and Signals
EQ Option Volumes & Open Interests (aggregated)
EQ Put Call Ratios and IV (aggregated)
EQ Financials
2025-10-24Bullishmacd_signal
Golden cross below zero detected.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-17Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.